To evaluate prognostic factors of biochemical recurrence (BCR) in each risk group of prostate cancer patients who underwent low‐dose‐rate brachytherapy (LDR‐BT). Click to show full abstract
To evaluate prognostic factors of biochemical recurrence (BCR) in each risk group of prostate cancer patients who underwent low‐dose‐rate brachytherapy (LDR‐BT).
               
Click one of the above tabs to view related content.